EAG K+ channel joins the p53xmiR-34xE2F1 signaling pathway as a terminal effecter component for its oncogenic overexpression and action

Zhiguo Wang,Chang Chen,Zhe Li,Xiaobin Luo,Jiening Xiao,Huixian Lin,Jianchun Zhang,De-Li Dong,Yanjie Lu,Baofeng Yang

DOI: https://doi.org/10.1038/npre.2010.4507.1

2010-01-01

Nature Precedings

Abstract:The human ether-x-go-go-1 (h-eag1) voltage-dependent K+ channel is necessary for cell cycle progression and its overexpression stimulates tumorigenesis; specific inhibition of h-eag1 expression leads to a reduction in tumor cell proliferation in vitro and in vivo. On the other hand, the tumor-suppressor gene p53 and its downstream genes consist of a complex molecular signaling network and p53 is at the center of this network regulating diverse physiological responses to cancer-related stresses. We report here that h-eag1 expression is controlled by the p53xmiR-34xE2F1 pathway through a negative feed-forward mechanism. We first established E2F1 as a transactivator of h-eag1 gene. We then revealed that miR-34, a known transcriptional target of p53, is an important negative regulator of h-eag1 through dual mechanisms by directly repressing h-eag1 at the post-transcriptional level and indirectly silencing h-eag1 at the transcriptional level via repressing E2F1. The antisense against h-eag1 antagonized the growth-stimulating effects and the upregulation of h-eag1 expression in SHSY5Y cells, induced by E2F1 overexpression, inhibition of p53 activity, or knockdown of miR-34. Thus, negative regulation of p53 causes oncogenic overexpression of h-eag1 by relieving the negative feed-forward regulation of the p53xmiR-34xE2F1 pathway or overexpression of h-eag1 fulfills the oncogenic cell growth-stimulating effect of p53 inactivation.